Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
HBM Healthcare Investments
AddedFeb 13, 2024
UpdatedJun 28, 2026
HBM Healthcare Investments

HBM Healthcare Investments

Operating

HBM Healthcare Investments AG is a Swiss venture capital firm, investing in emerging biotech and medical sectors, focusing on high-potential private companies.

Location
Zug, Zug, CH
Founded
2001
Firm
Compare
Portfolio
Employees
Website

HBM Healthcare Investments AG is a Swiss venture capital firm specializing in the biotechnology, human medicine, diagnostics, and medical technology sectors. The firm primarily focuses on high-potential private companies, with two-thirds of its assets invested in unlisted companies. HBM typically participates in Series A through Series E funding rounds, with significant investments in Series B and C stages.

Notable portfolio companies include Freenome, Harmony Biosciences, and Odyssey Therapeutics. Key partners and decision-makers at HBM bring extensive industry experience, contributing to the firm's robust investment philosophy centered on value creation. HBM Healthcare Investments offers unique value-add services such as strategic guidance and operational support to help portfolio companies scale effectively.

HBM Healthcare Investments - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments87
Current Portfolio Count43
Total Portfolio Exits2

Top Investment Stages

Series B25 (33.8%)
Series C22 (29.7%)
Series A11 (14.9%)
Series D9 (12.2%)
Convertible Note7 (9.5%)

Stage Mix

Series B 34%Series C 30%Series A 15%Series D 12%Convertible Note 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Odyssey Therapeutics logo

Odyssey Therapeutics

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

Upstream Bio logo

Upstream Bio

Numab logo

Numab

Fog Pharmaceuticals logo

Fog Pharmaceuticals

Valo Health logo

Valo Health

Mahzi Therapeutics logo

Mahzi Therapeutics

Fore Biotherapeutics logo

Fore Biotherapeutics

Shape Memory Medical logo

Shape Memory Medical

Vascular Dynamics logo

Vascular Dynamics

Dren Bio logo

Dren Bio

Karius logo

Karius

Freenome logo

Freenome

Neuron23 logo

Neuron23

Antiva Biosciences logo

Antiva Biosciences

NiKang Therapeutics logo

NiKang Therapeutics

Neurelis logo

Neurelis

eGenesis logo

eGenesis

Genalyte logo

Genalyte

Werewolf Therapeutics logo

Werewolf Therapeutics

Seer logo

Seer

C4 Therapeutics logo

C4 Therapeutics

Jianke logo

Jianke

iTeos Therapeutics logo

iTeos Therapeutics

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

HBM Healthcare Investments - Similar Investment Firms

HBM Partners logo

HBM Partners

hbmpartners.com

BioMedPartners logo

BioMedPartners

biomedvc.com

Hbm-Medfocus logo

Hbm-Medfocus

medfocusfunds.com

RBV Capital logo

RBV Capital

rbvcapital.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

BB Biotech Ventures logo

BB Biotech Ventures

Hambrecht Healthcare Growth Venture Fund logo

Hambrecht Healthcare Growth Venture Fund

HTH logo

HTH

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Hikma Ventures logo

Hikma Ventures

hikmaventures.com

Hambro Perks logo

Hambro Perks

Helicase Venture logo

Helicase Venture

CB Health Ventures logo

CB Health Ventures

Health Enterprise Partners logo

Health Enterprise Partners

hepfund.com

PA MedTech VC Fund logo

PA MedTech VC Fund

HBM Healthcare Investments - Classification

Also Known As
  • HBM Healthcare Investments AG
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end